These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22475089)

  • 1. Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead.
    Kumar G; Shafiq N; Malhotra S
    Crit Rev Ther Drug Carrier Syst; 2012; 29(2):149-82. PubMed ID: 22475089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLGA nanoparticles in drug delivery: the state of the art.
    Bala I; Hariharan S; Kumar MN
    Crit Rev Ther Drug Carrier Syst; 2004; 21(5):387-422. PubMed ID: 15719481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
    Mehta AK; Yadav KS; Sawant KK
    Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system.
    Kona S; Dong JF; Liu Y; Tan J; Nguyen KT
    Int J Pharm; 2012 Feb; 423(2):516-24. PubMed ID: 22172292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.
    Wang Y; Li P; Kong L
    AAPS PharmSciTech; 2013 Jun; 14(2):585-92. PubMed ID: 23463262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monodisperse PLA/PLGA nanoparticle fabrication through a surfactant-free route.
    Liang R; Zhu J
    J Control Release; 2011 Nov; 152 Suppl 1():e129-31. PubMed ID: 22195799
    [No Abstract]   [Full Text] [Related]  

  • 10. Concepts and practices used to develop functional PLGA-based nanoparticulate systems.
    Sah H; Thoma LA; Desu HR; Sah E; Wood GC
    Int J Nanomedicine; 2013; 8():747-65. PubMed ID: 23459088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the release characteristics of estradiol encapsulated in PLGA particles via surface coating.
    Enayati M; Stride E; Edirisinghe M; Bonfield W
    Ther Deliv; 2012 Feb; 3(2):209-26. PubMed ID: 22834198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization.
    Santander-Ortega MJ; Bastos-González D; Ortega-Vinuesa JL; Alonso MJ
    J Biomed Nanotechnol; 2009 Feb; 5(1):45-53. PubMed ID: 20055105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral and spatial characterization of protein loaded PLGA nanoparticles.
    Zidan AS; Rahman Z; Habib MJ; Khan MA
    J Pharm Sci; 2010 Mar; 99(3):1180-92. PubMed ID: 19774658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation.
    Van de Ven H; Vermeersch M; Matheeussen A; Vandervoort J; Weyenberg W; Apers S; Cos P; Maes L; Ludwig A
    Int J Pharm; 2011 Nov; 420(1):122-32. PubMed ID: 21864661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.
    Hines DJ; Kaplan DL
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):257-76. PubMed ID: 23614648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
    Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
    J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
    Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
    Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
    J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
    Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
    Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.